Skip to main content
. 2013 Feb 25;8(2):e57079. doi: 10.1371/journal.pone.0057079

Figure 2. Average changes in (A) spontaneous AP firing rate, (B) ATP and (C) cAMP by decreasing CaMKII activity with KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L).

Figure 2

*p<0.05 vs. drug control. #p<0.05 vs. drug low concentration.